Table 1:

Eligibility criteria.

Inclusion criteria

• Age ≥18 years • [K+] >5.0 mmol/l collected during standard of care within 21 days prior to the date of enrolment • Provision of informed consent

Exclusion criteria

• Concurrent participation in any trial that includes the use of K+ binders as an investigational medicinal product • Patients with pseudo-hyperkalaemia • Acute causes of hyperkalaemia, such as infections and/or trauma, to be determined by the principal investigator • Life expectancy of <6 months, based on physician judgement • Kidney transplant anticipated or planned during the study period • Involvement in the planning and/or conduct of the study